PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Faculty of Medicine, Université Laval, Québec, QC, Canada; High Altitude Pulmonary and Pathology Institute IPPA, La Paz, Bolivia. Electronic address: jorge.soliz@criucpq.ulaval.ca.\', \'Institute of Veterinary Physiology, Vetsuisse-Faculty University of Zurich, Winterthurerstrasse 260, Switzerland.\', \'Institute Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Faculty of Medicine, Université Laval, Québec, QC, Canada.\', \'High Altitude Pulmonary and Pathology Institute IPPA, La Paz, Bolivia.\', \'Florey Institute of Neuroscience and Mental Health, Melbourne Victoria, Australia; The Florey Department of Neuroscience, University of Melbourne, Melbourne Victoria, Australia.\', \'Florey Institute of Neuroscience and Mental Health, Melbourne Victoria, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1569-9048(20)30134-810.1016/j.resp.2020.103476
?:doi
?:hasPublicationType
?:journal
  • Respiratory physiology & neurobiology
is ?:pmid of
?:pmid
?:pmid
  • 32522574
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all